RhoGDI2 as a therapeutic target in cancer

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 1, 2010, Pages 67-75

  Cho, Hee Jun ^a   Baek, Kyoung Eun ^a   Yoo, Jiyun ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

Gastric cancer; Invasion; Metastasis; Rac; RhoGDI2

Indexed keywords

BETA1 INTEGRIN; CYCLOOXYGENASE 2; ENDOTHELIN 1; GUANOSINE TRIPHOSPHATASE; NEUROMEDIN B; RAC1 PROTEIN; REGULATOR PROTEIN; RHO GDP DISSOCIATION INHIBITOR 2; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN C;

CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; DRUG TARGETING; HUMAN; METASTASIS POTENTIAL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE PROGRESSION; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 72549117655     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903449251     Document Type: Review

References (79)

1. Steeg PS. Metastasis: a therapeutic target for cancer. Nat Clin Prac Oncol 2008;5(4):206-219
2. Nobes CD, Hall A. Rho, Rac and Cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 1995;23(3):456-459
3. Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett 2001;165(1):1-10
4. Vega FM, Ridley AJ. RhoGTPases in cancer cell biology. FEBS Lett 2008;582(14):2093-2101
5. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420(6916):629-635
6. Gomez del Pulgar T, Benitah SA, Valeron PF, et al. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 2005;27(6):602-613
7. Bishop AL, Hall A. RhoGTPases and their effector proteins. Biochem J 2000;348(Pt 2):241-255
8. Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002;16(13):1587-1609
9. Moon SY, Zheng Y. Rho GTPase-activation proteins in cell regulation. Trends Cell Biol 2003;13(1):13-22
10. Ueda T, Kikuchi A, Ohga N, et al. Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20; a ras p21-like GTP-binding protein. J Biol Chem 1990;265(16):9373-9380
11. Fukumoto Y, Kaibuchi K, Hori Y, et al. Molecular cloning and characterization of novel type of regulatory protein (GDI) for the Rho proteins, ras p21-like small GTP-binding proteins. Oncogene 1990;5(9):1321-1328
12. Dovas A, Couchman JR. RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 2005;390(Pt1):1-9
13. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 1999;11(8):545-554
14. Leonard D, Hart M, Platko J, et al. The identification and characterization of a GDP-dissociation inhibitor (GDI) for the Cdc42Hs proteins. J Biol Chem 1992;267(32):22860-22868
15. Zalcman G, Closson V, Camonis J, et al. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG. J Biol Chem 1996;271(48):30366-30374
16. Adra CN, Manor D, Ko JL, et al. RhoGDIgamma: a GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc Natl Acad Sci 1997;94(9):4279-4284
17. Lelias JM, Adra CN, Wulf GM, et al. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the Rho GTP-binding proteins. Proc Natl Acad Sci 1993;90(4):1479-1483
18. Scherle P, Behrens T, Staudt LM. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc Natl Acad Sci 1993;90(16):7568-7572
19. DerMardirossian C, Bokoch GM. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005;15(7):356-363
20. Dovas A, Couchman JR. RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J 2005;390(Pt 1):1-9
21. Dransart E, Olofsson B, Cherfils J. RhoGDIs revisited: novel roles in Rho regulation. Traffic 2005;6(11):957-966
22. Zhang B. Rho GDP dissociation inhibitors as potential targets for anticancer treatment. Drug Resist Updat 2006;9(3):134-141
23. Golovanov AP, Chuang TH, DerMardirossian C, et al. Structure- activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. J Mol Biol 2001;305(1):121-135
24. Longenecker K, Read P, Derewenda U, et al. How RhoGDI binds Rho. Acta Crystallogr D Biol Crystallogr 1999;55(Pt 9):1503-1515
25. Grizot S, Fauré J, Fieschi F, et al. Crystal structure of the Rac1-RhoGDI complex involved in NADPH oxidase activation. Biochemistry 2001;40(34):10007-10013 (Pubitemid 32800107)
26. Hoffman GR, Nassar N, Cerione RA. Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 2000;100(3):345-356
27. Scheffzek K, Stephan I, Jensen ON, et al. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol 2000;7(2):122-126
28. Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 2001;294(5545):1299-1304
29. Keep NH, Barnes M, Barsukov I, et al. A modulator of rho family G proteins, rhoGDI, binds these G proteins via an immunoglobulin-like domain and a flexible N-terminal arm. Structure 1997;5(5):623-633
30. Gosser YQ, Nomanbhoy TK, Aghazadeh B, et al. C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 1997;387(6635):814-819
31. Robbe K, Otto-Bruc A, Chardin P, et al. Dissociation of GDP dissociation inhibitor and membrane translocation are required for efficient activation of Rac by the Dbl homology-pleckstrin homology region of Tiam. J Biol Chem 2003;278(7):4756-4762
32. Mehta D, Rahman A, Malik AB. Protein kinase C-alpha signals Rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J Biol Chem 2001;276(25):22614-22620
33. DerMardirossian C, Schnelzer A, Bokoch GM. Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase. Mol Cell 2004;15(1):117-127
34. DerMardirossian C, Rocklin G, Seo JY, et al. Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling. Mol Biol Cell 2006;17(11):4760-4768
35. Takahashi K, Sasaki T, Mammoto A, et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/ moesin initiates the activation of the Rho small G protein. J Biol Chem 1997;272(37):23371-23375
36. Kim O, Yang J, Qiu Y. Selective activation of small GTPase RhoA by tyrosine kinase Etk through its pleckstrin homology domain. J Biol Chem 2002;277(33):30066-30071
37. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003;6(5):461-467
38. Chuang TH, Bohl BP, Bokoch GM. Biologically active lipids are regulators of Rac.GDI complexation. J Biol Chem 1993;268(35):26206-26211
39. Fauré J, Vignais PV, Dagher MC. Phosphoinositide-dependent activation of Rho A involves partial opening of the RhoA/Rho-GDI complex. Eur J Biochem 1999;262(3):879-889
40. Yonemura S, Matsui T, Tsukita S, et al. Rho-dependent and -independent activation mechanisms of ezrin/radixin/ moesin proteins: an essential role for polyphosphoinositides in vivo. J Cell Sci 2002;115(Pt 12):2569-2580
41. Fievet BT, Gautreau A, Roy C, et al. Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol 2004;164(5):653-659
42. Abramovici H, Mojtabaie P, Parks RJ, et al. Diacylglycerol kinase z regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI. Mol Biol Cell 2009;20(7):2049-2059
43. Ma L, Xu G, Sotnikova A, et al. Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma. Br J Haematol 2007;139(2):217-223
44. Seraj MJ, Harding MA, Gildea JJ, et al. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metastasis 2000;18(6):519-525
45. Gildea JJ, Seraj MJ, Oxford G, et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002;62(22):6418-6423
46. Theodorescu D, Sapinoso LM, Conaway MR, et al. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 2004;10(11):3800-3806
47. Titus B, Frierson HF Jr, Conaway M, et al. Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. Cancer Res 2005;65(16):7320-7327
48. Wu Y, McRoberts K, Berr SS, et al. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 2007;26(5):765-773
49. Tapper J, Kettunen E, El-Rifai W, et al. Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 2001;128(1):1-6
50. Zhang Y, Zhang B. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 2006;66(11):5592-5598
51. Zhang Y, Rivera Rosado LA, Moon SY, et al. Silencing of D4-GDI inhibits growthand invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling. J Biol Chem 2009;284(19):12956-12965
52. Schunke D, Span P, Ronneburg H, et al. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells. Cancer Res 2007;67(22):10694-10702
53. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2003;2:29: published online 20 August 2003, doi:10.1186/1476-4598-2-29 (Pubitemid 38751468)
54. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005;41(16):2462-2478
55. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2(2):91-100
56. Larkins TL, Nowell M, Singh S, et al. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006;6:181: published online 10 July 2006, doi:10.1186/1471-2407-6-181 (Pubitemid 44335961)
57. Jiang WG, Watkins G, Lane J, et al. Prognostic value of Rho GTPases and Rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003;9(17):6432-6440
58. Hu LD, Zou HF, Zhan SX, et al. Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. Oncol Rep 2007;17(6):1383-1389
59. Cho HJ, Baek KE, Park SM, et al. RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 2009;15(8):2612-2619
60. Adra CN, Ko J, Leonard D, et al. Identification of a novel protein with GDP dissociation inhibitor activity for the ras-like proteins CDC42Hs and Rac 1. Genes Chromosomes Cancer 1993;8(4):253-261
61. Gorvel JP, Chang TC, Boretto J, et al. Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity. FEBS Lett 1998;422(2):269-273
62. Moissoglu K, McRoberts KS, Meier JA, et al. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. Cancer Res 2009;69(7):2838-2844
63. Wu Y, Moissoglu K, Wang H, et al. Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc Natl Acad Sci 2009;106(14):5807-5812
64. Huang CY, Yang LC, Liu KY, et al. ZAK negatively regulates RhoGDIbeta-induced Rac1-mediated hypertrophic growth and cell migration. J Biomed Sci 2009;16:56: published online 18 June 2009, doi:10.1186/1423-0127-16- 56
65. Huang CY, Yang LC, Liu KY, et al. RhoGDIbeta-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK. J Biomed Sci 2009;16:11: published online 22 January 2009, doi:10.1186/1423-0127-16-11
66. Liu TC, Huang CJ, Chu YC, et al. Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif. Biochem Biophys Res Commun 2000;274(3):811-816
67. Sun D, Xu D, Zhang B. Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 2006;9(6):274-287
68. Groysman M, Hornstein I, Alcover A, et al. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways. J Biol Chem 2002;277(51):50121-50130
69. Hancock JF, Hall A. A novel role for RhoGDI as an inhibitor of GAP proteins. EMBO J 1993;12(5):1915-1921
70. Kweon SM, Cho YJ, Minoo P, et al. Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor. J Biol Chem 2008;283(6):3023-3030
71. Pommier Y, Cherfils J. Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery. Trends Pharmacol Sci 2005;26(3):138-145
72. Zeghouf M, Guibert B, Zeeh JC, et al. Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans 2005;33(Pt 6):1265-1268
73. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391(6669):806-811 (Pubitemid 28099681)
74. Zimmermann TS, Lee AC, Akinc A, et al. RNAi-mediated gene silencing in non-human primates. Nature 2006;441(7089):111-114
75. Fritz G, Kaina B. Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006;6(1):1-14
76. Walker K, Olson MF. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr Opin Genet Dev 2005;15(1):62-68
77. Gao Y, Dickerson JB, Guo F, et al. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci 2004;101(20):7618-7623
78. Guillemot JC, Kruskal BA, Adra CN, et al. Targeted disruption of guanosine diphosphate-dissociation inhibitor for Rho-related proteins, GDID4: normal hematopoietic differentiation but subtle defect in superoxide production by macrophages derived from in vitro embryonal stem cell differentiation. Blood 1996;88(7):2722-2731
79. Yin L, Schwartzberg P, Scharton-Kersten TM, et al. Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases. Mol Immunol 1997;34(6):481-491